PDCD1 and melanoma: Additionally, in clinical trials, fecal microbial transplantation (FMT) abrogated resistance to anti-PD-1 therapy in melanoma patients and made the treatment naïve patients more susceptible to anti-PD-1 therapy thus indicating that gut dysbiosis could cause T-cell exhaustion that is then reversed by FMT (76).